Gilead’s share price has surged after health experts said its antiviral drug remdesivir is showing signs of efficacy against the deadly COVID-19 coronavirus outbreak.
A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that work against the COVID-19 coronavirus – including a project investiga
Teva’s late stage trials of a potential drug for Tourette Syndrome have drawn a blank, just when the troubled pharma needs to freshen up its portfolio.
